A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677).

Authors

Perry JR; Laperriere N; O'Callaghan CJ; Brandes AA; Menten J; Phillips C; Fay MF; Nishikawa R; Cairncross JG; Roa W

Journal of Clinical Oncology, Vol. 34, No. 15_suppl, pp. lba2–lba2

American Society of Clinical Oncology (ASCO)

May 20, 2016

10.1200/jco.2016.34.15_suppl.lba2

0732-183X

Holger Hirte